Jeffrey Tate - Apr 20, 2023 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Operating Officer, Director
Signature
/s/ Jeffrey Tate
Stock symbol
CYTH
Transactions as of
Apr 20, 2023
Transactions value $
$25,001
Form type
4
Date filed
4/24/2023, 11:00 AM
Previous filing
Mar 9, 2023
Next filing
Oct 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Purchase $21.3K +29.9K +93.1% $0.71 62.1K Apr 20, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Warrant to Purchase Common Stock Purchase $3.74K +29.9K $0.13* 29.9K Apr 20, 2023 Common Stock 29.9K $0.71 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.